THE COMPARATIVE EFFICACY AND LONG-TERM EFFECT OF CLOZAPINE TREATMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE

被引:233
作者
BUCHANAN, RW
HOLSTEIN, C
BREIER, A
机构
[1] Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD
关键词
SCHIZOPHRENIA; NEUROPSYCHOLOGICAL TESTING; CLOZAPINE; NEGATIVE SYMPTOMS; POSITIVE SYMPTOMS; QUALITY OF LIFE;
D O I
10.1016/0006-3223(94)90082-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have suggested that clozapine may improve neuropsychological test performance. The current study was designed to examine the comparative efficacy and the long-term effect of clozapine (versus haloperidol), on neuropsychological test performance. Neuropsychological measures of executive/attention, visuospatial, and memory function were administered to schizophrenic patients at baseline, at the end of a 10-week double-blind study, and after 1 year of open clozapine treatment. Symptoms and function ratings were obtained at the same time points. The 10-week double-blind study revealed significant group-by-time interactions for two measures: Categorical Fluency and WAIS-R Block Design. At the end of 1 year of open treatment there were significant improvements in Verbal Fluency, Mooney Faces Closure, and WAIS-R Block Design performance, and trend improvements in Stroop Color-Word Interference, Category Fluency, and WMS-R Logical Memory performance. Improvements in neuropsychological performance were unrelated to symptom changes. Change in selected neuropsychological measures were significantly correlated with improvement in quality of life. The results suggest that long-term clozapine treatment may have beneficial effects on a broad range of cognitive functions.
引用
收藏
页码:717 / 725
页数:9
相关论文
共 50 条
[31]   Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics [J].
Han, Mei ;
Zhang, Xiang Yang ;
Chen, Da Chun ;
Tan, Yun Long ;
Song, Chong Sheng ;
Yu, Ying Hua ;
Huang, Xu Feng .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (02) :89-95
[32]   Add-on Cariprazine in Patients with Long-term Clozapine Treatment and Treatment Resistant Schizophrenia: Two Cases of Psychotic Deterioration and Pisa Syndrome [J].
Weise, Judith ;
Schomerus, Georg ;
Speerforck, Sven .
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (02) :398-401
[33]   Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine [J].
Galletly, CA ;
Clark, CR ;
McFarlane, AC ;
Weber, DL .
PSYCHIATRY RESEARCH, 1997, 72 (03) :161-166
[34]   Plasma clozapine concentration coefficients of variation in a long-term study [J].
Diaz, FJ ;
de Leon, J ;
Josiassen, RC ;
Cooper, TB ;
Simpson, GM .
SCHIZOPHRENIA RESEARCH, 2005, 72 (2-3) :131-135
[35]   Long-term outcome of clozapine use for psychosis in parkinsonian patients [J].
Fernandez, HH ;
Donnelly, EM ;
Friedman, JH .
MOVEMENT DISORDERS, 2004, 19 (07) :831-833
[36]   CLOZAPINE AS A LONG-TERM THERAPEUTIC CHOICE: LONGITUDINAL ANALYSIS OF SCHIZOPHRENIA SYMPTOMS IN A NATURALISTIC SETTING [J].
Scheinberg, Rachel ;
Fu, Zhirui ;
Scott, Laura ;
Baker, Krista ;
Cuerdo, Arlene ;
Zhong, Lillian ;
Bethany, Chloe ;
Harper, Malaka ;
Nucifora, Leslie ;
Brandt, Allison ;
Margolis, Russell ;
Yenokyan, Gayane ;
Nucifora, Frederick .
NEUROPSYCHOPHARMACOLOGY, 2024, 49 :519-519
[37]   Longitudinal analysis of abnormal involuntary movements in long-term clozapine-treated patients [J].
Bunker, MT ;
Sommi, RW ;
Stoner, SC ;
Switzer, JL .
PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (04) :699-703
[38]   Development of a nomogram for the estimation of long-term adherence to clozapine therapy using neutrophil fluorescence [J].
Man, W. H. ;
Perez-Pitarch, A. ;
Wilting, I ;
Heerdink, E. R. ;
van Solinge, W. W. ;
Egberts, A. C. G. ;
Huitema, A. D. R. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (06) :1228-1237
[39]   Metabolic predictors for mortality among patients treated with long-term clozapine - A longitudinal study [J].
Taub, Sharon ;
Hoshen, Moshe ;
Balicer, Ran ;
Kamhi-Nesher, Shiri ;
Weizman, Abraham ;
Krivoy, Amir .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 41 :63-69
[40]   Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia [J].
Daniel, DG ;
Wozniak, P ;
Mack, RJ ;
McCarthy, BG .
PSYCHOPHARMACOLOGY BULLETIN, 1998, 34 (01) :61-69